FOSUN HEALTH Logo

Neuromyelitis Optica (NMO) Overview

catalogue

Neuromyelitis Optica (NMO) Overview

Neuromyelitis Optica (NMO) Overview

Neuromyelitis optica spectrum disorder is the condition most often mistaken for multiple sclerosis, and mistaking it is expensive in a way few diagnostic errors are — because several of the medicines that treat multiple sclerosis make this one worse. The target here is not the myelin but the astrocyte , and specifically the aquaporin-4 water channel on its surface; in most people the condition is named by an antibody drawn from blood rather than by a lumbar puncture. The two signatures are the optic nerve and the spinal cord: an optic neuritis that is severe, often bilateral or rapidly sequential, and recovers less well than it does in multiple sclerosis; and a myelitis that runs lengthwise along the cord and leaves a sensory level, weakness and a bladder that has changed. A third presentation belongs in the same breath because it is the one most often missed for weeks: intractable vomiting, retching and hiccups with no explanation found in the abdomen. And the decisive fact about the prognosis is where it is made: disability here is made of attacks, not of silence — so the entire treatment question is preventing the next one, and getting this one treated within hours rather than days.

Neuromyelitis Optica (NMO) Overview
  • written opinion once complete records arrive

  • the antibody that names this is drawn from a vein

  • where the disability is made — not silence between them

  • countries and regions our international patients come from

What neuromyelitis optica is

The name is old and it is not a good one, because it describes the two places the condition most often shows itself — the optic nerve and the spinal cord — rather than what it is. What it is, is an autoimmune disease in which the target is the astrocyte: a support cell of the central nervous system, carrying on its surface a water channel called aquaporin-4. An antibody binds to that channel, complement is activated, the astrocyte is injured, and the nerve fibres that depended on it are damaged secondarily. That is a different sequence from what happens in multiple sclerosis, where the immune attack is directed at the myelin and at the axon beneath it.

The practical consequence of that difference is not academic. It is the reason the two conditions are named by different tests, followed by different imaging, and treated with different medicines — and it is the reason several of the agents used in multiple sclerosis, including some of the most effective ones, are associated with worse outcomes in this condition rather than better ones.

What the condition looks like, then, is a small number of recognisable attacks rather than a slow decline. An optic neuritis that takes vision severely and gives back less than the optic neuritis of multiple sclerosis does. A myelitis that runs along the cord rather than across it, leaving a level below which sensation is altered and the limbs and the bladder behave differently. And, less often and later recognised, an attack on the area postrema at the base of the brainstem which presents as vomiting and hiccups and is investigated for weeks in the wrong place.

Two sentences carry the rest of this guide. The first: the disability in this condition is made of attacks rather than of silence, which is unlike multiple sclerosis and is the reason the treatment question here is almost entirely about preventing the next one. The second: the attack that is happening now is the one that will be lived with, which is why treatment within hours rather than days is not a nicety.

The three names, and why they are not interchangeable

Three labels are in circulation and they are regularly used as though they were one. They are not, and what separates them is what the blood shows.

Name What the blood shows What the distinction changes
AQP4-IgG-positive NMOSD Aquaporin-4 antibody detected by cell-based assay on serum The diagnosis is made, and maintenance immunosuppression is the treatment — not the standard multiple sclerosis agents
MOG antibody disease (MOGAD) MOG antibody detected, with the aquaporin-4 antibody negative A different condition with a different course: attacks are often steroid-responsive, and the tendency to relapse is lower than in AQP4-positive disease
Seronegative NMOSD Neither antibody detected, at least on the assays and at the time it was drawn A stricter combination of clinical and imaging features is required, and the antibody may be worth repeating during a relapse

One practical point about that last row, because it is the one that costs people years. A negative antibody result is not the same as no antibody. The assay matters — cell-based assays perform differently from older methods — the timing matters, and the result can be negative while someone is on immunosuppression. Where the clinical picture fits and the test was negative, it is worth repeating during a relapse rather than closing the question.

What makes an attack urgent

In multiple sclerosis, a relapse is usually a matter of days to arrive and weeks to resolve, and it is rarely a reason to be in an emergency department tonight. In this condition the arithmetic is different, because an attack is where the disability is made. What follows is what changes the timescale, and what each one warrants.

Feature What it warrants
Visual loss that is severe from the outset, or that involves both eyes within days Assessment now, and the antibody drawn before any treatment is started. Bilateral and sequential optic neuritis is characteristic here in a way it is not in multiple sclerosis
A sensory level on the trunk, weakness in the legs, and a bladder that has stopped working properly Imaging of the cord now, with contrast. This is the shape of a longitudinally extensive myelitis, and the hours matter
Vomiting, retching or hiccups lasting days with no gastrointestinal cause found Not a gastroenterology problem once the abdomen has been looked at. This is the area postrema syndrome, and it belongs in this pathway
Weakness or sensory change that is at its worst within seconds or minutes The shape of a stroke rather than of an inflammatory attack. Emergency assessment now, and the question of which condition this is asked afterwards
A deterioration with fever, or someone becoming hard to rouse Infection or another acute condition until shown otherwise. Both worsen this condition and both are missed for it
Symptoms that come on with heat and resolve within the hour Not an attack. The same damage conducting worse at a higher temperature, which is a management problem rather than a reason for more immunosuppression
A slow increase in stiffness and slowing over a year, with no attack anyone can point to Not the usual shape of this condition. Where it happens, the structural causes of a compressed cord are excluded before anything else is assumed

The error to avoid is the reverse of this table as well: an attack being watched for a few days to see whether it resolves on its own. In a condition where the disability is made of attacks, waiting is not neutral — it is the single most available way to make the outcome worse.

How the diagnosis is assembled

The assessment is not a single test that comes back positive. It is a clinical pattern, an imaging finding, and — in most people — an antibody in the blood. Alongside them sits a second job that is done far less often than it should be: excluding the conditions that look like this one, multiple sclerosis most of all.

Item What it establishes What it does not do
Aquaporin-4 antibody on serum, cell-based assay Names the condition in most people who have it, and separates it from multiple sclerosis Not a test done on spinal fluid, and not a result that is fixed for ever. It can be negative on one assay and positive on another, or negative while immunosuppressed
MOG antibody on serum Names a different condition where the aquaporin-4 antibody is negative, and changes the expected course Not a test that means the same thing in every clinical setting. A transient positivity in a child after a single episode is read differently from a persistent one
MRI of the cord, with contrast A longitudinally extensive lesion — three or more vertebral segments — which is characteristic here and unusual in multiple sclerosis Not seen at all where only the brain is imaged. This is the commonest technical omission in the workup of this condition
MRI of the brain Excludes a great deal, and in this condition is frequently normal or shows change that does not satisfy multiple sclerosis criteria Not the study that makes the diagnosis. A normal brain scan in someone with a cord lesion and positive antibodies is entirely compatible with this condition
MRI of the orbits with contrast Involvement of the optic nerve, and how far along it the signal runs Not always abnormal, and an old optic neuritis can leave the nerve looking unremarkable years later
Spinal fluid Excludes infection and other inflammation; the cell count and protein are often raised during an attack Oligoclonal bands are absent in most people with this condition. Their presence should prompt the multiple sclerosis question again rather than settle this one
Blood tests for the mimics The autoimmune and infectious conditions that produce the same picture, and the thyroid and lupus antibodies that travel with this one Not a substitute for the antibody test itself. A file full of negative autoimmune screens with no AQP4 result is a file in which the decisive test was not sent
The history, in order What happened first, how fast, whether it recovered and how completely — which is often where the second attack, and therefore the dissemination, is hiding Not a formality. An episode six years ago that was never written down is regularly the most valuable item in the file

Why patients travel to China for a neuromyelitis optica assessment

Most of what families are looking for here is not a new treatment. It is an answer to a question that was never asked: whether the aquaporin-4 and MOG antibodies were ever tested, and whether the treatment that has been running is the right one for the disease that is actually there. That question is answered from records more often than not, which is why the first step is a written opinion rather than a journey.

Where the person does need to be here, what an assessment adds is the assembly: neurology, imaging, rehabilitation and neuropsychology contributing to one plan rather than four letters, with the cord and the orbits imaged as a matter of course rather than on request. The programme is supported by 3.0T magnetic resonance imaging, dual-source computed tomography, positron emission tomography, three-dimensional digital subtraction angiography, long-term video electroencephalography, the full spinal fluid set, and evoked potentials — and by antibody testing arranged as part of the workup rather than as an afterthought.

What should not be assumed is that a particular medicine is available here. Where a medicine recommended is not carried out within this pathway, that is named at the outset, before any payment is discussed — not at the end of a workup. Where the honest answer is that the plan already running is the right one and nothing here would change it, that is said as plainly as the alternative, and it is not converted into an itinerary.

Frequently Asked Questions

Is neuromyelitis optica a kind of multiple sclerosis?

No, and this is the single most consequential thing on this page. The two look alike at the bedside — an optic neuritis, a myelitis, a young adult with a first episode — and they are managed differently. The target in this condition is the astrocyte rather than the myelin, the antibody test is on blood rather than spinal fluid, oligoclonal bands are usually absent, and the disability comes from attacks rather than from silent accumulation. Most importantly, several of the medicines used to treat multiple sclerosis are known to make this condition worse. That is why the antibody result is asked for before a treatment is started rather than after.

If my MRI shows lesions, does that settle it?

Not on its own, and in this condition the image is frequently less informative than the blood test. The brain scan in neuromyelitis optica is often normal or shows change that does not look like multiple sclerosis; the finding that carries weight is on the cord, where a lesion spanning three or more vertebral segments is characteristic, and on the orbits, where the optic nerve can be shown to be involved. What settles the diagnosis in most people is a positive aquaporin-4 antibody on a cell-based assay of serum. A scan without that test is a scan with an unanswered question attached.

Why does the antibody test matter so much?

Because two things follow from it, and both are large. The first is the diagnosis itself: a positive aquaporin-4 antibody by cell-based assay names the condition, and where it is negative, a stricter combination of clinical and imaging features is required and the MOG antibody becomes the next question. The second is the treatment: several multiple sclerosis therapies that would be reasonable in multiple sclerosis are associated with worse outcomes in this condition, and the maintenance treatment used here is immunosuppression rather than the standard multiple sclerosis agents. The test is drawn on blood, not by lumbar puncture.

Can the attacks be stopped?

The disease cannot be prevented, but the next attack largely can, and that is the whole of the treatment question here — because disability in this condition is made of attacks rather than of something accumulating quietly between them. Continuous maintenance immunosuppression reduces attack frequency; treating the attack that is happening within hours rather than days reduces what it leaves behind; and avoiding the multiple sclerosis agents that worsen this condition removes a harm that is entirely avoidable. What cannot be prevented is the condition itself, and what replaces prevention there is recognition: an attack treated early leaves less than the same attack treated late.

Find out whether the antibody was ever tested, and what the answer changes

Send the imaging with its reports — brain, cord and orbits, in date order — any spinal fluid result, and the list of antibody tests that were performed. If the aquaporin-4 and MOG antibodies were never sent, say so plainly; it is the single most useful thing we can tell you. Our team will return a written opinion on whether the diagnosis is secure, what is worth testing next, and whether travelling would change the plan, before any travel is arranged.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*